It makes a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays, and its laboratory quality assessment products (QAPs™) and reference ...
Sino Biological has launched an extensive portfolio of recombinant antigens for the 2026-2027 Northern Hemisphere influenza ...
The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...
Human respiratory syncytial virus (RSV) remains a significant public health concern, particularly for vulnerable populations such as infants, young children, and immunocompromised individuals. In this ...
Dr. Mark Luscher, SVP of Scientific Affairs, highlights the relevance of the Microbix recombinants program, "Our teams have deep expertise in making antigen products that have the properties needed to ...
MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (MBX:CA)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage ...
MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix), a life sciences innovator, manufacturer, and exporter, announces the commercial usage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results